KBC Securities - BIOTALYS NV (BTLS) Biotalys 1H25 underscores its prudent and cost-efficient operating strategy

Report

KBC Securities

Guy Sips

Biotalys 1H25 underscores its prudent and cost-efficient operating strategy

Biotalys' 1H25 financials, including a cash position of €15.7m at period-end, underscore its disciplined and cost-conscious strategy, providing a financial runway through May 2026. We maintain our Buy and € 6.1 Target Price.

18/09/2025 1 EN

Underlying

BIOTALYS NV

See profile

BE0974386188 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Guy Sips

Other Reports on these Companies

KBC Securities

Morning Notes : NEXTA BB, SOF BB, UCB BB, BTLS BB, ONWD BB, EXO NA

: NEXTA BB, SOF BB, UCB BB, BTLS BB, ONWD BB, EXO NA

September 18, 2025 September 18, 2025 1 EN

KBC Securities

Morning Notes : ACKB BB, HAL NA, NEXTA BB, RECT BB, RET BB, UCB BB, BTLS BB, ECMPA NA

: ACKB BB, HAL NA, NEXTA BB, RECT BB, RET BB, UCB BB, BTLS BB, ECMPA NA

August 29, 2025 August 29, 2025 1 EN

Arcadis Key take-aways analyst call

This morning Arcadis reported numbers (as written in our FRN) which were at P&L level roughly inline with our forecasts but below consensus. FCF was weak at €80m down from €134m in 4Q25 linked to timing of billing milestones and issues linked with the implementation of Oracle at the 2023 IBI acquisition. Before opening we downgraded to Hold (from Accumulate) as the stock rallied considerably since the announcement of a €175m SBB early October. On top we saw no room for outperformance on our numbers which are arguably somewhat below consensus. Worries on the FCF generation, order intake and con...

10h / 58m 10h / 58m 1 EN

Jacob Mekhael

Jacob Mekhael

argenx FIRST LOOK: 3Q25 conference call takeaways

Key takeaways from argenx 3Q25 earnings call summarised in this note.

12h / 23m 12h / 23m 1 EN

Guy Sips

Guy Sips

Materialise Additional listing on Euronext Brussels & SBB

Materialise announced its plans to pursue an additional listing of its ordinary shares on Euronext Brussels, to complement the existing Nasdaq listing. Materialise also launches a buyback program.

13h / 41m 13h / 41m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Biotalys 1H25 underscores its prudent and cost-efficient operating strategy

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : NEXTA BB, SOF BB, UCB BB, BTLS BB, ONWD BB, EXO NA

Morning Notes : ACKB BB, HAL NA, NEXTA BB, RECT BB, RET BB, UCB BB, BTLS BB, ECMPA NA

Arcadis Key take-aways analyst call

argenx FIRST LOOK: 3Q25 conference call takeaways

Materialise Additional listing on Euronext Brussels & SBB

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe